Drug Trial Radar · NCT02193087
Safety and Immunogenicity of Three Formulations of Takeda's Tetravalent Dengue Vaccine Candidate (TDV)
Last checked: Nov 19, 2026Latest source record: Jul 18, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,002
Actual
Start
Aug 6, 2014
Primary completion
May 19, 2015
Study completion May 19, 2015
Sponsor
- Lead sponsor
- TakedaTakeda (TAK)
- Sponsor type
- Industry
- First posted
- Jul 17, 2014
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Basic science
- Who can join
- All sexes, from 18 years, up to 49 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the equivalence of the lyophilized formulation of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) compared with the liquid formulation of TDV.
Conditions
- Dengue Fever
Interventions
TDV Liquid Formulation 1Drug
TDV Liquid Formulation 1 for subcutaneous injection
TDV Liquid Formulation 2Drug
TDV Liquid Formulation 2 for subcutaneous injection
TDV IDT LyophilizedDrug
TDV Lyophilized Formulation for subcutaneous injection
PlaceboDrug
TDV liquid formulation placebo-matching solution for subcutaneous injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Geometric Mean Titer (GMT) of Neutralizing Antibodies for Each of the Four Dengue Serotypes Comparing Group D To Groups A and B CombinedTime frame: Month 1
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Hope Research Institute
Phoenix, Arizona
Anaheim Clinical Trials, LLC
Anaheim, California
Clinical Research Atlanta
Stockbridge, Georgia
Advanced Clinical Research
Meridian, Idaho
Johnson County Clin-Trials
Lenexa, Kansas
Clinical Research Center of Nevada
Las Vegas, Nevada
Tekton Research
Austin, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.